During the past 15 years Moraxella (Branhamella) catarrhalis has been reported with increasing frequency as a cause of acute exacerbations in patients with chronic obstructive pulmonary disease and of acute otitis media in children (3) . The isolation of M. catarrhalis from clinical samples is not sufficient evidence of its role as a pathogen, because nasopharyngeal carriage is common in healthy persons, especially children and adults more than 60 years old (22) .
Among possible targets for the immune system are outer membrane proteins (OMPs). OMP preparations of M. catarrhalis have been used in an enzyme-linked immunosorbent assay (ELISA) to examine immune responses in children with acute otitis media (11), but they have not previously been used to investigate immunoglobulin responses in patients with bronchopulmonary infection.
In the study described here, a Western blot (immunoblot) method for detecting antibodies against OMP epitopes of M. catarrhalis was evaluated for its ability to detect crossreactivity to related species and other respiratory tract pathogens in an immunoadsorption experiment. Paired serum samples from patients suspected of M. catarrhalis and non-M. catarrhalis bronchopulmonary infection were then examined for the presence of immunoglobulin M (IgM)-, IgG-and IgA-class antibodies to the OMPs of M. catarrhalis by using a gel electrophoresis-immunoperoxidase technique.
MATERIALS AND METHODS
Strains. The M. catarrhalis type strain (strain CCUG 353) and the following six clinical M. catarrhalis isolates were examined for OMPs by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE): three strains from respiratory tract specimens (one strain each from Sweden, Denmark, and the United States [strain F 48, received from T. F. Murphy] [19] ), two blood culture strains (one received from R. E. Weaver, Centers for Disease Control and Prevention, Atlanta, Ga., and the other isolated in Denmark), and one strain isolated from an eye specimen (received from R. E. Weaver).
In the Western blot analysis experiments for the detection of antibodies, a mixture of all strains except strain F 48 was used.
For immunoadsorption experiments the following strains were used: M. Isolation of outer membranes. Outer membranes were isolated from broth culture supernatants as described by Bartos and Murphy (1) . The protein concentration was adjusted to 10 g/liter in sample buffer (containing 4.0 ml of distilled water, 1.0 ml of 0.5 M Tris-HCl [pH 6.8], 0.8 ml of glycerol, 1.6 ml of 10% [wt/vol] SDS, 0.4 ml of 2-␤-mercaptoethanol, and 0.2 ml of 0.05% [wt/vol] bromphenol blue). The OMPs of all strains were characterized by using strain F 48 from Murphy as a reference strain.
SDS-PAGE. The outer membranes of the M. catarrhalis strains prepared as described above were heated at 100ЊC for 5 min (15) . PAGE was performed with 12.5% running gels at 180 V and 4% stacking gels at 120 V. The peptide bands were visualized with Coomassie blue.
Western blot analysis. Transfer of M. catarrhalis OMPs from the SDS-polyacrylamide gel onto a nitrocellulose membrane was performed in a Trans Blot Chamber (Bio-Rad); this was followed by washing with Tris-buffered saline (TBS) and blocking with ovalbumin and Tween 20 for 1 h as described previously (8) . After the addition of patient serum, diluted 1:100 in blocking solution, and further incubation at 22ЊC overnight, the paper was washed in TBS containing 0.01% Tween 20. Horseradish peroxidase-labelled rabbit antibodies to human IgG, IgM, or IgA (Dako, Glostrup, Denmark; unwanted antibodies were re-moved by solid-phase absorption with human plasma proteins, and specificity was checked by crossed-immunoelectrophoresis and ELISA), diluted 1:500 in blocking solution, were added for 1 h. New washings followed, and finally, horseradish peroxidase color development reagent (Bio-Rad) containing 4-chloro-1-naphthol was added. Control with no patient serum and with serum from a patient with M. catarrhalis isolated from blood cultures were also performed.
Immunoadsorption experiments. To test for cross-reactions between M. catarrhalis OMPs and surface epitopes from other species (species either taxonomically related to M. catarrhalis or representing other respiratory tract pathogens), serum from a patient from whose blood M. catarrhalis had been isolated was adsorbed with the bacterial species prior to Western blot analysis. The serum was diluted 1:1,000 in blocking solution. The various bacteria were grown on horse blood agar plates overnight, washed two times in saline (by centrifugation at 4,000 ϫ g for 5 min), and resuspended to 10% (wt/wt) in either saline (for immediate use) or 2% formalin-NaCl (used after 2 h of incubation at 37ЊC). A bacterial suspension of 5 ml was centrifuged, the sediment was washed twice and resuspended in 5 ml of the diluted serum, and the mixture was rotated overnight at 4ЊC. After centrifugation (4,000 ϫ g for 5 min) the supernatant was used in the Western blot analysis with rabbit antibodies to human IgG. Adsorption experiments were done twice with identical results.
Patient sera. Acute-and convalescent-phase sera (convalescent-phase sera were obtained 1 to 2 weeks after the acute-phase sera were taken) from the following two patient groups were examined: (i) 38 patients suspected of bronchopulmonary infection from whom M. catarrhalis alone (n ϭ 29) or together with S. pneumoniae or H. influenzae, or both (n ϭ 9), was isolated from the lower respiratory tract and (ii) 25 patients suspected of bronchopulmonary infection from whom S. pneumoniae (n ϭ 5), H. influenzae (n ϭ 10), or N. meningitidis (n ϭ 8) alone or in combination (n ϭ 2) was isolated from the lower respiratory tract. Only specimens from patients whose lower respiratory tract specimens revealed granulocytes and/or cylindrical epithelium with few or no squamous epithelial cells on microscopy were included. Demographic and clinical data for the patients are presented in Table 1 and have been reported previously (6, 7) . Serum from a 74-year-old woman from whose blood cultures M. catarrhalis was isolated was used as control, because it contained IgM-, IgG-, and IgA-class antibodies against most OMPs recognized by the tested sera from patients and blood donors. Serum samples from 40 adult blood donors were also included (median age, 58 years; age range, 50 to 64 years).
Statistical method. Fisher's exact test was used for statistical analysis.
RESULTS

OMP patterns.
The OMP patterns obtained by SDS-PAGE of the seven M. catarrhalis strains studied were similar, but minor differences were found (Fig. 1) . Approximately 25 bands with molecular masses of between 140 and 16 kDa could be identified, with six to eight of these being the major bands A to H, with molecular masses of 98, 84, 72, 69, 56, 43, 28, and 21 kDa described by Bartos and Murphy (1) . The SDS-PAGE patterns of the mixed OMP preparation included all bands recognized for individual strains. Strain F 48 produced nearly all OMPs present in the mixed OMP preparation, and the results obtained with strain F 48 were similar to previous results of Murphy and Loeb (19) . The intensities of the bands and the bands that were present varied slightly between strains.
Immunoadsorption experiments. Fig. 2 .
IgM-class antibodies against OMPs of M. catarrhalis were found in acute-and/or convalescent-phase sera from 22 of 38 (58%) patients (Table 2) with M. catarrhalis in their lower respiratory tract specimens; antibodies against one to seven (median, three) OMPs were found in each positive serum. IgM-class antibodies were found in 8 of 25 (32%) patients without M. catarrhalis in their lower respiratory specimens; antibodies against two to six (median, three) OMPs were found in each positive serum specimen. The sera of 6 of 40 (15%) blood donors had IgM-class antibodies against OMPs of M. catarrhalis; antibodies against one to two (median, one) OMPs were found in each positive serum specimen. IgM-class antibodies were found more often in patients with M. catarrhalis than in blood donors (P ϭ 0.0002), whereas IgM-class antibodies were found equally often in patients with the other respiratory pathogens and in blood donors (P ϭ 0.19). a Diagnostic criteria: rectal temperature, Ն38.5ЊC; increasing amounts of cough and purulent expectoration; absence of infiltrates on X ray.
b Bronchopulmonary infection was present together with infiltrates on X ray. c In three patients M. catarrhalis was found in pure culture, while in three patients M. catarrhalis was found in an admixture with S. pneumoniae (n ϭ 2) and H. influenzae (n ϭ 1).
IgG-class antibodies against M. catarrhalis OMPs were found in acute-phase sera from all except two patients with M. catarrhalis and from all blood donors (Table 2 ). In acutephase sera, there were no significant differences with regard to the number of serum IgG-class antibodies directed against different OMPs between patients with M. catarrhalis (median, 6; range, 0 to 14), patients without M. catarrhalis (median, 8; range, 2 to 17), and blood donors (median, 7; range, 2 to 15). An increase in the number of different IgG-class antibodies, from acute-to convalescent-phase serum, against OMPs of M. catarrhalis was found for 19 of 38 (50%) patients with M. catarrhalis and 4 of 25 (16%) patients without M. catarrhalis (Table 3) .
IgA-class antibodies were found in acute-phase serum from 25 of 38 (66%) patients with M. catarrhalis, in sera from 21 of 25 (84%) patients without M. catarrhalis, and in sera from 30 of 40 (75%) blood donors ( Table 2 ). In acute-phase sera there were no significant differences with regard to the number of serum IgA-class antibodies directed against different OMPs between patients with M. catarrhalis (median, four; range, one to eight), patients without M. catarrhalis (median, three; range, one to eight), and blood donors (median, two; range, one to five). An increased number of IgA-class antibodies directed against different OMPs, from acute-to convalescent-phase serum, was found in sera from 13 of 38 (34%) (median, three; range, one to nine) patients with M. catarrhalis and the serum of 1 of 25 (4%) (one IgA-class antibody band) patients without M. catarrhalis. The sera of eight of these latter patients had
FIG. 2. Results of Western blot analysis examinations in which OMPs
of M. catarrhalis were tested with sera from four patients suspected of having bronchopulmonary infection caused by M. catarrhalis. Sera were tested for the presence of IgM (A), IgG (B), and IgA (C) against OMPs of M. catarrhalis. Lanes 1 and 2, negative and positive controls, respectively (i.e., no addition of serum and addition of serum from a patient whose blood yielded growth of M. catarrhalis on culture); lanes 2b and 2c, the positive control was diluted 1:2 and 1:4, respectively; lanes 3 and 4 (sera from patient 1), 5 and 6 (sera from patient 2), 7 and 8 (sera from patient 3), and 9 and 10 (sera from patient 4) provide results for acute-and convalescent-phase sera (for each pair of lanes, respectively) from four patients with different antibody response patterns; IgM-class antibody responses are seen for patients 1, 2, and 4; increased IgG-class antibody responses in convalescent-phase sera are seen for all patients; increased IgA-class antibody responses in convalescent-phase sera are seen for patients 1, 2, and 4. (Table 2) . Of the patients with M. catarrhalis, 11 patients had IgM-class antibodies and increased numbers of IgG-class antibodies in their convalescent-phase sera, 11 patients had IgM-class antibodies and 8 patients had an increased number of IgG-class antibodies. Of the patients without M. catarrhalis, two had IgM-class antibodies and an increased number of IgG-class antibodies, six had IgM-class antibodies in their convalescent-phase sera, and two had an increased number of IgG-class antibodies in their convalescent-phase sera.
DISCUSSION
Murphy and Loeb (19) have examined five procedures for the isolation of OMPs and compared the results with the results obtained by the sucrose gradient technique (19) . Two of the procedures, those that used broth culture supernatants (which was used in the present study) and EDTA-heat-induced vesicles, resulted in OMP SDS-PAGE patterns comparable to the patterns obtained after sucrose density centrifugation, which is considered the "gold standard." The OMPs of M. catarrhalis strains of various geographical and anatomical origins demonstrate little variability, as shown by Bartos and Murphy (1) and as also seen in the present study. With regard to OMP production, the F 48 strain described by Murphy and Loeb (19) appeared to be very representative, because it produces nearly all OMPs produced by different M. catarrhalis strains. Some OMPs have been shown to be antigenically conserved among different M. catarrhalis strains (13, 18, 21) , suggesting that, in an immune response to OMP antigens of one strain, a second strain might be recognized (11) . In the control serum, from a patient from whose cultured blood M. catarrhalis was isolated, antibodies against practically all OMPs were present, thereby being an indirect marker of the sensitivity of the detection method.
When evaluating the significance of antibodies against M. catarrhalis, it is important to render it probable that the antibody responses are specific for M. catarrhalis. This was demonstrated by the immunoadsorption experiment, in which only M. ovis, M. bovis, and M. lacunata demonstrated epitopes that cross-reacted with four M. catarrhalis OMPs; these three species are, however, extremely rarely isolated from humans.
The method used, Western blotting, allows for the recognition of the production of antibodies to OMPs of M. catarrhalis, in spite of an already existing antibody response to other OMPs. This is of importance because it has been shown that the sera of many healthy adults already have IgG-and IgAclass antibodies (9, 12) against M. catarrhalis, as was also seen in the present study. The major OMPs, A to H, described by Murphy and coworkers (1, 19) were major targets for antibody responses, but other OMPs also often elicited an antibody response. A significantly more frequent occurrence of either IgM-class antibodies and/or an increased number of IgG-class antibodies against different M. catarrhalis OMPs from acute-to convalescent-phase sera was found in patients with M. catarrhalis than in patients without M. catarrhalis. This supports a pathogenic role of the bacterium in patients with signs of bronchopulmonary infection from whom M. catarrhalis is isolated from the lower respiratory tract. Other methods that have been used to demonstrate an immune response to M. catarrhalis in patients with pulmonary infections are (i) the demonstration of bactericidal activity in convalescent-phase sera (4); (ii) the use of whole-cell antigen to demonstrate rises in the titers of IgGand/or IgA-class antibodies in convalescent-phase sera (2, 8, 14) by immunofluorescence or ELISA techniques; and (iii) demonstration of rises in IgG-class antibody titers against the P protein (5, 10), an M. catarrhalis OMP. Generally, the convalescent-phase sera of approximately 50% of patients suspected of having M. catarrhalis infection elicited an increased antibody response to the organism. Using a whole-cell protein suspension as antigen, we previously found (8) IgG-class antibodies against a 28-kDa protein more frequently in patients suspected of M. catarrhalis bronchopulmonary infection than in patients suspected of non-M. catarrhalis bronchopulmonary infection. However, the supposition that the 28-kDa protein was an OMP could not be verified in the present study, illustrating the difficulties in correlating results when using different serological methods.
Bacteriological findings in relation to acute exacerbations of chronic bronchitis change from episode to episode, which may explain some of the IgM-class antibody responses among patients from whom M. catarrhalis was not isolated from the lower respiratory tract. For IgA-and IgG-class antibody responses, the time interval between the times that the two serum samples were obtained may have been inadequate to observe seroconversion. Fourteen patients had an increased number of IgA-class antibodies against different M. catarrhalis OMPs in their convalescent-phase sera, and M. catarrhalis was not isolated from only 1 of these 14 patients, strongly associating increased numbers of IgA-class antibodies with the presence of M. catarrhalis.
As a diagnostic test, the method described here is not useful because antibody production is not restricted only to patients suspected of M. catarrhalis bronchopulmonary infection. In relation to the reported increase in the number of acute otitis media episodes alleged to be caused by this bacterium, the OMPs of M. catarrhalis have been mentioned as potential components of a vaccine (17) . However, no uniform pattern of antibodies elicited in relation to infection occurred; therefore, it is very difficult to comment on the possible protective capabilities of the individual OMPs of M. catarrhalis.
The exact role of bacterial infections in patients with chronic bronchitis is not known (20) . Bacterial infection does not appear to initiate the disease, but bacteria probably play a major role in the characteristic acute exacerbations (16, 20) . The present study indicates that M. catarrhalis should be considered one of the bacteria involved in acute exacerbations of chronic bronchitis.
